Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases.
Wagner, M
Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases. [electronic resource] - Clinical and experimental dermatology Jul 2012 - 527-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2230
10.1111/j.1365-2230.2011.04291.x doi
Animals
Biomarkers, Tumor--metabolism
Disease Models, Animal
Enzyme Inhibitors--therapeutic use
Female
Glucuronidase--metabolism
Immunohistochemistry
Melanoma, Experimental--drug therapy
Methylene Blue--therapeutic use
Mice
Mice, Nude
Photochemotherapy--methods
Photosensitizing Agents--therapeutic use
Proliferating Cell Nuclear Antigen--metabolism
Skin Neoplasms--drug therapy
Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases. [electronic resource] - Clinical and experimental dermatology Jul 2012 - 527-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2230
10.1111/j.1365-2230.2011.04291.x doi
Animals
Biomarkers, Tumor--metabolism
Disease Models, Animal
Enzyme Inhibitors--therapeutic use
Female
Glucuronidase--metabolism
Immunohistochemistry
Melanoma, Experimental--drug therapy
Methylene Blue--therapeutic use
Mice
Mice, Nude
Photochemotherapy--methods
Photosensitizing Agents--therapeutic use
Proliferating Cell Nuclear Antigen--metabolism
Skin Neoplasms--drug therapy